Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jason Labutti"'
Autor:
Mark Rolfe, Julie X. Zhang, Gabriel S. Weatherhead, Christopher A. Tsu, Yuan Tian, Matthew Stirling, Marjorie S. Solomon, Corinne L. Reimer, Ashok D. Patil, Anne M. Mazzola, Jason Labutti, Lawrence R. Dick, J. Scott Daniels, Yueying Cao, Frank J. Bruzzese, Jonathan L. Blank, Mark J. Williamson
Strains within the genus Salinospora have been shown to produce complex natural products having antibiotic and antiproliferative activities. The biochemical basis for the cytotoxic effects of salinosporamide A has been linked to its ability to inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5252834913f8cac5179e0fd33b018f31
https://doi.org/10.1158/1535-7163.c.6531429
https://doi.org/10.1158/1535-7163.c.6531429
Autor:
Mark Rolfe, Julie X. Zhang, Gabriel S. Weatherhead, Christopher A. Tsu, Yuan Tian, Matthew Stirling, Marjorie S. Solomon, Corinne L. Reimer, Ashok D. Patil, Anne M. Mazzola, Jason Labutti, Lawrence R. Dick, J. Scott Daniels, Yueying Cao, Frank J. Bruzzese, Jonathan L. Blank, Mark J. Williamson
Supplementary Fig. S2 from Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7d6b3c01afa13c5032c97a247196bc9
https://doi.org/10.1158/1535-7163.22484490
https://doi.org/10.1158/1535-7163.22484490
Autor:
Mark Rolfe, Julie X. Zhang, Gabriel S. Weatherhead, Christopher A. Tsu, Yuan Tian, Matthew Stirling, Marjorie S. Solomon, Corinne L. Reimer, Ashok D. Patil, Anne M. Mazzola, Jason Labutti, Lawrence R. Dick, J. Scott Daniels, Yueying Cao, Frank J. Bruzzese, Jonathan L. Blank, Mark J. Williamson
Supplementary Table S1 from Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6e3daae3978bdef7d650a92159c9248
https://doi.org/10.1158/1535-7163.22484487.v1
https://doi.org/10.1158/1535-7163.22484487.v1
Autor:
Mark Rolfe, Julie X. Zhang, Gabriel S. Weatherhead, Christopher A. Tsu, Yuan Tian, Matthew Stirling, Marjorie S. Solomon, Corinne L. Reimer, Ashok D. Patil, Anne M. Mazzola, Jason Labutti, Lawrence R. Dick, J. Scott Daniels, Yueying Cao, Frank J. Bruzzese, Jonathan L. Blank, Mark J. Williamson
Supplementary Fig. S1 from Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2434e76f2d4437cfbe11b0c130f29a2
https://doi.org/10.1158/1535-7163.22484493.v1
https://doi.org/10.1158/1535-7163.22484493.v1
Autor:
Vinita Uttamsingh, Mark G. Qian, Gerald T. Miwa, Liang-Shang Gan, Kym Cardoza, Sandeepraj Pusalkar, Ron Huang, Suresh K. Balani, Jing-Tao Wu, Wei Yin, Chuang Lu, Ping Li, Frank W. Lee, Hua Yang, Jason Labutti, Cindy Q. Xia, Nelamangala Nagaraja, J. Scott Daniels
Publikováno v:
Biotechnology: Pharmaceutical Aspects ISBN: 9780387340562
Efficacy and safety are the two key elements in the drug discovery and development processes. The primary goal for pharmaceutical research companies is to identify and manufacture therapeutic agents that are safe and efficacious for patients. In prin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b24a912dc8ab45e4db7aac8a219ab9fa
https://doi.org/10.1007/978-0-387-44961-6_4
https://doi.org/10.1007/978-0-387-44961-6_4
Autor:
Mark J. Williamson, Jonathan L. Blank, Frank J. Bruzzese, Yueying Cao, J. Scott Daniels, Lawrence R. Dick, Jason Labutti, Anne M. Mazzola, Ashok D. Patil, Corinne L. Reimer, Marjorie S. Solomon, Matthew Stirling, Yuan Tian, Christopher A. Tsu, Gabriel S. Weatherhead, Julie X. Zhang, Mark Rolfe
Publikováno v:
Molecular cancer therapeutics. 5(12)
Strains within the genus Salinospora have been shown to produce complex natural products having antibiotic and antiproliferative activities. The biochemical basis for the cytotoxic effects of salinosporamide A has been linked to its ability to inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcf376eca448b6183d3ffeb635a28ccb
https://pubmed.ncbi.nlm.nih.gov/17172407
https://pubmed.ncbi.nlm.nih.gov/17172407
Publikováno v:
Chemical research in toxicology. 19(4)
Bortezomib (1) is a potent first-in-class dipeptidyl boronic acid proteasome inhibitor employed in the treatment of patients with relapsed multiple myeloma where the disease is refractory to conventional lines of therapy. The potency of 1 is owed pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::504e5666eb4f12c4b4f4b2f050b7950d
https://pubmed.ncbi.nlm.nih.gov/16608165
https://pubmed.ncbi.nlm.nih.gov/16608165